Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Revenue by Product

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Ethical Pharmaceutical	49.57B
Ethical Pharmaceutical Growth	14.89%
Consumer Healthcare	26.00B
Consumer Healthcare Growth	3.64%
Other	154.74M
Other Growth	1.63%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Japan	36.75B
Japan Growth	2.09%
Europe	24.41B
Europe Growth	21.11%
United Kingdom	9.54B
United Kingdom Growth	30.19%
Other	5.03B
Other Growth	2.53%